Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy
Authors
Keywords
Hepatocellular carcinoma, Nucleolin, Expression, Tumor progression, Prognosis
Journal
Diagnostic Pathology
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-09-18
DOI
10.1186/s13000-014-0175-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas
- (2014) Liyu Li et al. BIOMATERIALS
- Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands
- (2014) Hirota Fujiki et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
- (2014) Marina Koutsioumpa et al. Recent Patents on Anti-Cancer Drug Discovery
- Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer
- (2013) Wensheng Qiu et al. APMIS
- Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
- (2013) J. F. Wise et al. BLOOD
- In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
- (2013) Flavia Pichiorri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nucleolin Mediates MicroRNA-directed CSF-1 mRNA Deadenylation but Increases Translation of CSF-1 mRNA
- (2013) Ho-Hyung Woo et al. MOLECULAR & CELLULAR PROTEOMICS
- Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer
- (2013) Hongyun Zhao et al. PLoS One
- Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death
- (2013) Sari Schokoroy et al. PLoS One
- Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway
- (2013) Xiangshan Yang et al. TUMOR BIOLOGY
- Upregulation of Bone Morphogenetic Protein 4 is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2012) Xiaodong Guo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Molecular Targeted Therapies in Hepatocellular Carcinoma
- (2012) Shinji Tanaka et al. SEMINARS IN ONCOLOGY
- Molecularly Targeted Therapy for Advanced Hepatocellular Carcinoma in 2012: Current Status and Future Perspectives
- (2012) Andrew X. Zhu SEMINARS IN ONCOLOGY
- Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis
- (2012) Mashaal Dhir et al. HPB
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: A historical prospective study
- (2011) Hemda Schmilovitz-Weiss et al. Diagnostic Pathology
- Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma
- (2011) Heng Hong et al. Diagnostic Pathology
- Survival Analysis I: The Kaplan-Meier Method
- (2011) Vianda S. Stel et al. NEPHRON CLINICAL PRACTICE
- Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo
- (2010) Hua Yang et al. CANCER LETTERS
- High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
- (2010) L. Peng et al. CLINICAL CANCER RESEARCH
- Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic–pathologic correlation
- (2010) Ahsun Riaz et al. JOURNAL OF HEPATOLOGY
- Variable Selection in the Cox Regression Model with Covariates Missing at Random
- (2009) Ramon I. Garcia et al. BIOMETRICS
- Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
- (2009) Michelle Z. Xu et al. CANCER
- Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patients
- (2009) Chien-Hung Chen et al. EUROPEAN JOURNAL OF CANCER
- Quantitative proteomic analysis of a paired human liver healthy versus carcinoma cell lines with the same genetic background to identify potential hepatocellular carcinoma markers
- (2009) Huimin Bao et al. Proteomics Clinical Applications
- Power and sample size calculation for log-rank test with a time lag in treatment effect
- (2009) Daowen Zhang et al. STATISTICS IN MEDICINE
- Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma
- (2008) Lee Ridley et al. NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now